Bromide

Bromide

SCHEMBL130779

Br.CCCCCCCCCCCCCCCCN(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 1/20 0.39
DNM1 Q05193 8/20 1.00
TSHR P16473 2/20 0.69
ALDH1A1 P00352 1/20 0.69
THRB P10828 1/20 0.50
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
S1PR2 O95136 1/20 0.41
S1PR1 P21453 1/20 0.41
S1PR3 Q99500 1/20 0.41
S1PR5 Q9H228 1/20 0.41
GBA1 P04062 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3014917 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL129468 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL7761001 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21253124 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21293895 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL9465223 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21250203 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21293896 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL21247774 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12
Bromide SCHEMBL238107 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260055056-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE WILLIAM M YARBROUGH FOUND (US) 2026-02-26 US claimed
US-12310939-B2 Method for treating rheumatoid arthritis THE WILLIAM YARBROUGH FOUNDATION (US) 2025-05-27 US claimed
US-20250161258-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE THE WILLIAM M YARBROUGH FOUND (US) 2025-05-22 US claimed
CN-120005681-A Silicon carbide substrate cleaning agent and preparation method and application thereof 广东麒瑞新材料科技有限公司 2025-05-16 CN claimed
CN-119842359-A High-stability multi-component hybrid structural adhesive for new energy lithium battery and preparation method thereof 博森新材料(烟台)有限公司 2025-04-18 CN claimed
CN-119776897-A Preparation method and application of unsupported catalyst electrode 北京化工大学 2025-04-08 CN claimed
CN-119680577-A Preparation method of zinc-based composite piezoelectric catalyst and application of zinc-based composite piezoelectric catalyst in piezoelectric catalytic hydrogen production 浙江精工集成科技股份有限公司 2025-03-25 CN claimed
US-12239626-B2 Method for treating infectious diseases with isothiocyanate functional compounds THE WILLIAM YARBROUGH FOUNDATION (US) 2025-03-04 US claimed
CN-119331295-A Extinction liquid for lens shading sheet, extinction lens shading sheet, preparation method and application of extinction liquid 拓烯科技(衢州)有限公司 2025-01-21 CN claimed
CN-119264808-A Composition, ionic gel coating, preparation method and application thereof 清华大学 2025-01-07 CN claimed
WO-2005032521-A2 NON-FLAMMABLE TOPICAL ANESTHETIC LIQUID AEROSOLS COLLEGIUM PHARMACEUTICAL, INC. (US) 2005-04-14 WO claimed
US-6838419-B2 Mixtures of quaternary compounds CRODA, INC. (US) 2005-01-04 US claimed
US-20040167057-A1 Mixtures of quaternary compounds CRODA, INC. 2004-08-26 US claimed
US-6514862-B2 Particles, solvent and a quaternary ammonium compound such as (2-hydroxyethyl)trimethylammonium chloride; improved removal selectivity between a layer to be polished and a silicon nitride stop layer SAMSUNG ELECTRONICS CO. LTD. (KR) 2003-02-04 US claimed
US-20020064955-A1 Wafer polishing slurry and chemical mechanical polishing (CMP) method using the same CONVERSANT INTELLECTUAL PROPERTY MANAGEMENT INC. (CA) 2002-05-30 US claimed
US-6283336-B1 Article for the delivery of foam products THE PROCTER & GAMBLE COMPANY 2001-09-04 US claimed
US-5580422-A INCLUSION OF A QUATERNARY COMPOUND PRODUCES A FIBER WITH HIGHER PULP STRENGTH HOECHST CELANESE CORPORATION (US) 1996-12-03 US claimed
US-5356748-A Nonaqueous solvent containing dispersed resin grains and graft polymer stabilizer FUJI PHOTO FILM CO., LTD. (JP) 1994-10-18 US claimed
US-4429457-A Process for manufacturing a printed circuit board TOPPAN PRINTING CO., LTD. (JP) 1984-02-07 US claimed
US-4105545-A PROCESS FOR REMOVING CYANIDE-CONTAINING COMPONENTS FROM AQUEOUS MEDIA TREADWELL CORP. (US) 1978-08-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055056-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE ALK, C9, MSR1 SIGMAR1 449/4885DNM1 4860/4885TSHR 1094/4885
US-12239626-B2 Method for treating infectious diseases with isothiocyanate functional compounds CFTR, TST, ICMT SIGMAR1 1678/4885DNM1 3945/4885TSHR 1685/4885
US-12310939-B2 Method for treating rheumatoid arthritis MIF, TNF, MMP12 SIGMAR1 1339/4885DNM1 3267/4885TSHR 1301/4885
US-20250161258-A1 ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE TST, TMSB10, NHERF1 SIGMAR1 1720/4885DNM1 3740/4885TSHR 4015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.